Vigmed Holding AB (publ) published the Annual Report for 2015 today.
The report is available on the company website: https://www.vigmed.com/investor
Shareholders and other interested parties who wish to receive a printed copy of
the Annual Report 2015 may order it via email: alexandra.lindgren@vigmed.com.
The Annual Report is also available as an attachment to this press release.
For further information contact:
Chairman of the board, Lennart Holm +46 70 630 8562 or CEO, Henrik Olsen +46 76
349 7364
Vigmed is a Swedish medical technology company whose mission is to eliminate
needlestick injuries and the associated risk of cross infections with blood
-borne infectious diseases by offering the market unique needle-protected
products. Vigmed is headquartered in Helsingborg, Sweden. Vigmed’s share is
traded on NASDAQ OMX First North in Stockholm (ticker VIG) and has
approximately 5 600 shareholders. Remium Nordic AB is the Company’s Certified
Advisor. Additional information about the company can be found on Vigmed’s
website: www.vigmed.com/investor
